HIV infection: how effective is drug combination treatment? (Q77567246)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818549%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

HIV infection: how effective is drug combination treatment? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818549%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

Z Grossman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818549%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

M Feinberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818549%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

V Kuznetsov

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818549%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

D Dimitrov

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818549%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

W Paul

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818549%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818549%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818549%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818549%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818549%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

528-532

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818549%20AND%20SRC:MED&resulttype=core&format=json

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

T-cell homeostasis in HIV infection is neither failing nor blind: modified cell counts reflect an adaptive response of the host

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

Sequential antigen-specific growth of T cells in the T zones and follicles in response to pigeon cytochrome c

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

HIV gets a taste of its own medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

HIV-1: gambling on the evolution of drug resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901353-X

7 January 2021

10.1016/S0167-5699(98)01353-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818549%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference